Other
Financing — other
Amgen Financing — other decreased by 13.0% to -$104.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 285.2%, from -$27.00M to -$104.00M.
Analysis
StatementIncome Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Large fluctuations may indicate one-time financing adjustments or changes in cash management strategies that require further investigation.
Detailed definition
Net cash flows resulting from miscellaneous financing activities that do not fall under debt issuance, equity issuance,...
Peer comparison
Highly variable across companies depending on their specific accounting for miscellaneous financing items.
Metric ID:
other_proceeds_from_payments_for_other_financing_activitiesHistorical Data
16 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$33.00M | -$19.00M | -$26.00M | -$26.00M | -$61.00M | $0.00 | -$28.00M | -$53.00M | -$5.00M | -$90.00M | -$40.00M | $0.00 | -$2.00M | -$27.00M | -$92.00M | -$104.00M |
| QoQ Change | — | +42.4% | -36.8% | +0.0% | -134.6% | +100.0% | — | -89.3% | +90.6% | <-999% | +55.6% | +100.0% | — | <-999% | -240.7% | -13.0% |
| YoY Change | — | — | — | +21.2% | -221.1% | — | -7.7% | -103.8% | — | -221.4% | +24.5% | — | +60.0% | +70.0% | -130.0% | -285.2% |
Range-$104.00M – $0.00
CAGR+35.8%
Avg YoY Growth-79.3%
Median YoY Growth-55.8%
Current Streak3 quarters decline
Financing — other at Other Companies
Frequently Asked Questions
- What is Amgen's financing — other?
- Amgen (AMGN) reported financing — other of -$104.00M in Q1 2026.
- How has Amgen's financing — other changed year-over-year?
- Amgen's financing — other decreased by 285.2% year-over-year, from -$27.00M to -$104.00M.
- What does financing — other mean?
- Net cash movement from non-standard financing activities.